During the past decade, an abundance of new evidence highlighted the importance of
inflammation in the development of chronic pathologies such as neurodegeneration, cancer …

Tumour-promoting inflammation is considered one of the enabling characteristics of cancer
development. Chronic inflammatory disease increases the risk of some cancers, and strong …

Inflammation is a recognised hallmark of cancer that substantially contributes to the
development and progression of malignancies. In established cancers, there is increasing …

Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) are
important components of the tumor microenvironment, which have been reported to localize …

BACKGROUND Predicting survival is uniquely difficult in patients with pancreatic cancer
who receive chemotherapy. The authors developed a systemic inflammation response index …

Haemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome, which if not
promptly treated, can lead rapidly to critical illness and death. HLH is termed macrophage …

Thymoquinone is an active ingredient isolated from Nigella sativa and has been
investigated for its anti-oxidant, anti-inflammatory and anticancer activities in both in vitro …

Hepatocellular carcinoma (HCC), the most common primary liver tumor, is notoriously
resistant to systemic therapies, and often recurs even after aggressive local therapies. HCCs …

The switch of tumor cells from an epithelial to a mesenchymal-like phenotype [designated as
epithelial-to-mesenchymal transition (EMT)] is known to induce tumor cell motility and …

Abstract Kaempferol (3, 5, 7-trihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one) is a
flavonoid found in many edible plants (eg, tea, broccoli, cabbage, kale, beans, endive, leek …